Sonablate
Sonablate is a privately held health care company focused on treating primary and recurrent prostate cancer using HIFU, a minimally invasive outpatient procedure which potentially improves patients’ quality of life. The company is focused on becoming a global market leader utilizing HIFU to revolutionize the delivery of minimally invasive patient care. US HIFU has established partnerships and relationships throughout the world, creating an extensive international presence by making HIFU technology available outside the U.S.
Funding
Every round, secondary, debt facility or acquisition involving Sonablate that AI Lounge tracks, newest first. Latest: Venture round on Aug 6, 2026.
Timeline · 2
In the news
Members see every AI company on AI Lounge with revenue, funding, valuation and investors, searchable and sortable, free.
Create my free account →Log in